Ranking Invest

Harmony Biosciences Holdings, Inc.

Segmento: Healthcare Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

Indicadores Básicos

Valor de Mercado

$ 2.09 Bi

IVR

0.60

IVR2

0.23

Índices de Previsibilidade

Faturamento

0.05

Lucro

0.38

Margem

0.35

Índices de Tendência

Faturamento

11.61

Lucro

4.61

Margem

2.70

Índices de Endividamento

DIV/PAT

-0.65

DIV/L4T

-3.09

Dívida Líquida

-$ 471.50 Mi

Patrimônio Líquido

$ 720.52 Mi

L4T

$ 152.72 Mi

MM4T

20.18%

Dívidas
Dividendos
Cotação: $36.40

Não há dados de histórico de dividendos para exibir.

Gráfico Lucro/Faturamento X Trimestre